What is MAC-MOD Analytical?
Established in 1986, MAC-MOD Analytical has evolved into a critical provider of HPLC and UHPLC columns, serving as a cornerstone for laboratories engaged in biotechnology, pharmaceutical development, and environmental monitoring. The company distinguishes itself through a specialized product portfolio that includes bioanalytical columns and safety-focused separation solutions. By integrating advanced software diagnostics with deep technical expertise, MAC-MOD Analytical assists researchers in optimizing complex separation workflows. Their market position is defined by a commitment to technical precision and a robust library of resources that support the rigorous demands of modern analytical science, ensuring that clients maintain high-throughput efficiency in their research and quality control processes.
How much funding has MAC-MOD Analytical raised?
MAC-MOD Analytical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in MAC-MOD Analytical
PPP
Public-Private Partnership
What's next for MAC-MOD Analytical?
Following this major strategic investment, MAC-MOD Analytical is poised to accelerate its innovation roadmap, likely focusing on the next generation of ultra-high-performance liquid chromatography technologies. As the firm transitions through this late-stage growth phase, the focus will shift toward scaling its operational footprint and expanding its reach into emerging biopharmaceutical markets. By prioritizing the development of application-specific columns and enhancing its digital support infrastructure, the company aims to solidify its competitive advantage. This capital injection provides the necessary liquidity to pursue strategic partnerships and R&D initiatives that will define the future of chromatographic separation, ensuring the firm remains at the forefront of the global analytical instrumentation industry.
See full MAC-MOD Analytical company page
